A Wee1 kinase inhibitor increased cytotoxicity of oncolytic adenoviruses in p53-deficient cells

被引：0
|
作者：
Morinaga, T. [1 ]
Thao, N. T. [1 ,2 ]
Boya, Z. [1 ,2 ]
Tagawa, M. [1 ,2 ]
机构：
[1] Chiba Canc Ctr, Res Inst, Div Pathol & Cell Therapy, Chiba, Japan
[2] Chiba Univ, Grad Sch Med, Dept Mol Biol & Oncol, Chiba, Japan
来源：
MOLECULAR BIOLOGY OF THE CELL | 2018年 / 29卷 / 26期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P1329
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [31] Id-1 promotes proliferation of p53-deficient esophageal cancer cells
    Hui, Cheuk Man
    Cheung, Pak Yan
    Ling, Ming Tat
    Tsao, Sai Wah
    Wang, Xianghong
    Wong, Yong Chuan
    Cheung, Annie L. M.
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (03) : 508 - 514
  • [32] Reduced expression of p27kiP1 and increased hepatocyte proliferation in p53-deficient mice
    Yang, CW
    Sun, MZ
    Ilic, Z
    Friedrich, TD
    Sell, S
    MOLECULAR CARCINOGENESIS, 2003, 36 (01) : 15 - 22
  • [33] Increased sensitivity of p53-deficient cells to anticancer agents due to loss of Pms2
    Fedier, A
    Ruefenacht, UB
    Schwarz, VA
    Haller, U
    Fink, D
    BRITISH JOURNAL OF CANCER, 2002, 87 (09) : 1027 - 1033
  • [34] Increased sensitivity of p53-deficient cells to anticancer agents due to loss of Pms2
    A Fedier
    U B Ruefenacht
    V A Schwarz
    U Haller
    D Fink
    British Journal of Cancer, 2002, 87 : 1027 - 1033
  • [35] Pharmacodynamic evaluation of pCDC2 and Wee1 signature as biomarkers of target engagement for the Wee1 tyrosine kinase inhibitor MK-1775
    Cheng, J. D.
    Tibes, R.
    Schellens, J. H.
    Shapiro, G. I.
    Pavlick, A. C.
    Oza, A. M.
    Xu, Y.
    Song, Y.
    Lam, R. L. H.
    Demuth, T.
    EJC SUPPLEMENTS, 2010, 8 (07): : 202 - 202
  • [36] Blastic transformation of p53-deficient bone marrow cells by p210(bcr/abl) tyrosine kinase
    Skorski, T
    NieborowskaSkorska, M
    Wlodarski, P
    Perrotti, D
    Martinez, R
    Wasik, MA
    Calabretta, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (23) : 13137 - 13142
  • [37] WEE1 Inhibitor Adavosertib Exerts Antitumor Effects on Colorectal Cancer, Especially in Cases with p53 Mutations
    Ariyoshi, Misa
    Yuge, Ryo
    Kitadai, Yuki
    Shimizu, Daisuke
    Miyamoto, Ryo
    Yamashita, Ken
    Hiyama, Yuichi
    Takigawa, Hidehiko
    Urabe, Yuji
    Oka, Shiro
    CANCERS, 2024, 16 (18)
  • [38] Strategic development of AZD1775, a Wee1 kinase inhibitor, for cancer therapy
    Fu, Siqing
    Wang, Yudong
    Keyomarsi, Khandan
    Meric-Bernstein, Funda
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (09) : 741 - 751
  • [39] MdmX regulates transformation and chromosomal stability in p53-deficient cells
    Matijasevic, Zdenka
    Krzywicka-Racka, Anna
    Sluder, Greenfield
    Jones, Stephen N.
    CELL CYCLE, 2008, 7 (19) : 2967 - 2973
  • [40] Chk1 suppresses bypass of mitosis and tetraploidization in p53-deficient cancer cells
    Wilsker, Deborah
    Chung, Jon H.
    Bunz, Fred
    CELL CYCLE, 2012, 11 (08) : 1564 - 1572
12345